Health Catalyst, Inc. (HCAT)

Market Cap	101.55M -62.1%
Revenue (ttm)	311.14M +1.5%
Net Income	-177.97M
EPS	-2.55
Shares Out	73.59M
PE Ratio	n/a
Forward PE	10.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	160,114
Open	1.320
Previous Close	1.330
Day's Range	1.290 - 1.380
52-Week Range	0.955 - 5.062
Beta	1.82
Analysts	Hold
Price Target	2.53 (+83.33%)
Earnings Date	May 8, 2026

About HCAT

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operat...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jul 25, 2019
• Employees: 1,200
• Stock Exchange: NASDAQ
• Ticker Symbol: HCAT
• Website: https://www.healthcatalyst.com

Financial Performance

In 2025, Health Catalyst's revenue was $311.14 million, an increase of 1.48% compared to the previous year's $306.58 million. Losses were -$177.97 million, 156.1% more than in 2024.

Analyst Summary

According to 10 analysts, the average rating for HCAT stock is "Hold." The 12-month stock price target is $2.53, which is an increase of 83.33% from the latest price.

Price Target

$2.53

(83.33% upside)

Analyst Consensus: Hold